Share This Author
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research…
These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
- O. Cornely, M. Bassetti, A. Ullmann
- Medicine, BiologyClinical Microbiology and Infection
- 1 December 2012
This part of the EFISG guidelines focuses on non-neutropenic adult patients, and liposomal amphotericin B and voriconazole are supported with moderate, and fluconazole with marginal strength for the targeted initial treatment of candidaemia.
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
The presence of a dominant resistance mechanism in clinical isolates suggests that isolates with this mechanism are spreading in the authors' environment, and might be more prevalent than currently acknowledged.
Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
- E. Snelders, R. A. G. Huis In 't Veld, A.J.M.M. Rijs, G. Kema, W. Melchers, P. Verweij
- BiologyApplied and Environmental Microbiology
- 17 April 2009
It is hypothesized that azole resistance might develop through azole exposure in the environment rather than in azole-treated patients, and it showed that environmental and clinical isolates were genetically clustered apart from nonresistant isolates.
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.
Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus
The findings support a fungicide-driven route of TR34/L98H development in Aspergillus fumigatus and have major implications for the assessment of health risks associated with the use of triazole DMIs.
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009
- J.W.M. van der Linden, E. Snelders, P. Verweij
- Medicine, BiologyEmerging Infectious Diseases
- 1 October 2011
The study found that multiazole resistance in A. fumigatus is widespread in the Netherlands and is associated with a high death rate for patients with invasive aspergillosis.